What is Rivaroxaban Market Scope?
Rivaroxaban is a drug which is an oral form of a drug. It is a prescription drug. It is sold under the brand name of Xarelto and is not available as a generic drug. This drug is used to treat and prevent the blood vessels from clotting. This drug is used to prevent stroke in people, prevent and treat the blood clots in the blood vessels. The blood clots are formed in certain veins like in the legs. The clots can also travel to the lungs causing pulmonary embolisms. They also prevent deep vein thromboses after knee or hip replacement surgery. This medication also reduces the risk of major heart problems such as heart attack or stroke in coronary artery disease or peripheral artery disease. The drug is consumed in addition to aspirin to reduce the risk of major heart problems in people with chronic artery disease or peripheral artery disease. This drug was first started by Bayer AG.
The Rivaroxaban market study is being classified, by Application (Deep Vein Thrombosis Prophylaxis and Pulmonary Embolism) and major geographies with country level break-up.
The companies are exploring the market by adopting mergers & acquisitions, expansions, investments, new service launches, and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions to avail a competitive advantage through combined synergies. Research Analyst at AMA predicts that Players from Asian will contribute to the maximum growth of Global Rivaroxaban market throughout the predicted period.
Bayer AG (Germany), Janssen Pharmaceuticals Inc. (United States), MITS Healthcare Pvt Limited (India), Wohltat Life Sciences (India), Healing Pharma India Pvt. Ltd (India), Psychocare Health Pvt Limited (India), Medicine Impex (India), SPR Oncocare Private Limited (India) and Kindcare Drugs Private Limited (India) are some of the key players profiled in the study. Additionally, the Players which are also part of the research are Akcent Healthcare India Private Limited (India) and Solisom Healthcare LLP (India).
Analyst at AMA have segmented the market study of Global Rivaroxaban market by Type, Application and Region.
On the basis of geography, the market of Rivaroxaban has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).
On October 30, 2017, Janssen Pharmaceuticals, Inc. had announced that the U.S. Food and Drug Administration (FDA) had approved the 10 mg once-daily dose of XARELTO® (rivaroxaban) for the purpose of reducing the continued risk for recurrent venous thromboembolism (VTE) after completing at least six months of initial anticoagulation therapy.
Influencing Market Trend
- The Rising Awareness About Mental Health
- A Rise in The Recommendation of Medical Experts to Consume the Drug to Overcome Hypertension
- Increase in The Number of Hip and Knee Replacement Surgeries
- Expanding Clinical Preliminaries
- Increase in Stress Levels
- Growing Improvements and Developments Across the Healthcare Industry
- Side Effects Caused by Drugs
- High Cost of Drugs
- Presence of Substitute Drugs
Key Target AudienceNew Entrants/Investors, Analysts and Strategic Business Planners, Manufacturers of Rivaroxaban, Suppliers and Distributors of Rivaroxaban, Venture Capitalists and Private Equity Firms and End-Use Industry
Customization available in this Study:The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
To compete effectively, companies also require quantitative estimates of the future growth and qualitative nature of the market. AMA Research & Media features not just specific market sizing estimates, but also include significant value-added commentary on Technological Trends and Innovations, Regulatory Policies, Market Maturity Indicators, Market Share Movements, New Entrants into the Market & Entry/Exit Barriers, Consumer Demographics, Supporting Company Financial and Cash Flow Planning, Open Up New Markets , To Seize Powerful Market Opportunities, Key Decision in Planning and to Further Expand Market Share, Identify Key Business Segments, Market Proposition & Gap Analysis.